Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 53

1.

RH421 binds into the ATP-binding site on the Na+/K+-ATPase.

Huličiak M, Bazgier V, Berka K, Kubala M.

Biochim Biophys Acta. 2017 Aug 1;1859(10):2113-2122. doi: 10.1016/j.bbamem.2017.07.016. [Epub ahead of print]

PMID:
28774819
2.

Inhibition of Na+/K+-ATPase by 5,6,7,8-tetrafluoro-3-hydroxy-2-phenylquinolin-4(1H)-one.

Šeflová J, Čechová P, Biler M, Hradil P, Kubala M.

Biochimie. 2017 Jul;138:56-61. doi: 10.1016/j.biochi.2017.04.009. Epub 2017 Apr 20.

PMID:
28435145
3.

Ion Pathways in the Na+/K+-ATPase.

Čechová P, Berka K, Kubala M.

J Chem Inf Model. 2016 Dec 27;56(12):2434-2444. doi: 10.1021/acs.jcim.6b00353. Epub 2016 Dec 14.

PMID:
27966362
4.

Cardiac resynchronisation therapy device implantation in a patient with persistent left superior vena cava: is it still a challenge?

Kubala M, Chadha GD, Renard C, Traullé S, Hermida JS.

Kardiol Pol. 2016;74(6):599. doi: 10.5603/KP.2016.0092. No abstract available.

5.

Flavonolignans As a Novel Class of Sodium Pump Inhibitors.

Kubala M, Čechová P, Geletičová J, Biler M, Štenclová T, Trouillas P, Biedermann D.

Front Physiol. 2016 Mar 30;7:115. doi: 10.3389/fphys.2016.00115. eCollection 2016.

6.

Electrochemical Platform for the Detection of Transmembrane Proteins Reconstituted into Liposomes.

Vacek J, Zatloukalova M, Geleticova J, Kubala M, Modriansky M, Fekete L, Masek J, Hubatka F, Turanek J.

Anal Chem. 2016 Apr 19;88(8):4548-56. doi: 10.1021/acs.analchem.6b00618. Epub 2016 Mar 28.

PMID:
26980181
7.

Flavonolignan 2,3-dehydroderivatives: Preparation, antiradical and cytoprotective activity.

Pyszková M, Biler M, Biedermann D, Valentová K, Kuzma M, Vrba J, Ulrichová J, Sokolová R, Mojović M, Popović-Bijelić A, Kubala M, Trouillas P, Křen V, Vacek J.

Free Radic Biol Med. 2016 Jan;90:114-25. doi: 10.1016/j.freeradbiomed.2015.11.014. Epub 2015 Nov 12.

PMID:
26582372
8.

Characterization of the part of N-terminal PIP2 binding site of the TRPM1 channel.

Jirku M, Bumba L, Bednarova L, Kubala M, Sulc M, Franek M, Vyklicky L, Vondrasek J, Teisinger J, Bousova K.

Biophys Chem. 2015 Dec;207:135-42. doi: 10.1016/j.bpc.2015.10.005. Epub 2015 Oct 27.

PMID:
26544986
9.

Feasibility and safety of temporary subcutaneous venous figure-of-eight suture to achieve haemostasis after ablation of atrial fibrillation.

Traullé S, Kubala M, Doucy A, Quenum S, Hermida JS.

Europace. 2016 Jun;18(6):815-9. doi: 10.1093/europace/euv266. Epub 2015 Oct 14.

PMID:
26467404
10.

Partial extravenous course of cardiac pacemaker leads. A major risk during device-assisted extraction.

Hermida JS, Caus T, Traullé S, Kubala M.

HeartRhythm Case Rep. 2015 Aug 28;1(6):506-508. doi: 10.1016/j.hrcr.2015.04.005. eCollection 2015 Nov. No abstract available.

11.

Synthesis and characterization of a helicene-based imidazolium salt and its application in organic molecular electronics.

Storch J, Zadny J, Strasak T, Kubala M, Sykora J, Dusek M, Cirkva V, Matejka P, Krbal M, Vacek J.

Chemistry. 2015 Feb 2;21(6):2343-7. doi: 10.1002/chem.201405239. Epub 2014 Dec 11.

PMID:
25504775
12.

Visualization of effects of cryoballoon ablation during percutaneous treatment of atrial fibrillation.

Traullé S, Kubala M, Hermida JS.

Arch Cardiovasc Dis. 2014 Oct;107(10):581-2. doi: 10.1016/j.acvd.2012.06.009. Epub 2014 Sep 11. No abstract available.

13.

Crystals of Na(+)/K(+)-ATPase with bound cisplatin.

Huliciak M, Reinhard L, Laursen M, Fedosova N, Nissen P, Kubala M.

Biochem Pharmacol. 2014 Dec 1;92(3):494-8. doi: 10.1016/j.bcp.2014.08.029. Epub 2014 Sep 6.

PMID:
25199459
14.

Na(+)/K(+)-ATPase inhibition by cisplatin and consequences for cisplatin nephrotoxicity.

Kubala M, Geleticova J, Huliciak M, Zatloukalova M, Vacek J, Sebela M.

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014 Jun;158(2):194-200. doi: 10.5507/bp.2014.018. Epub 2014 Apr 29.

15.

Antioxidant, metal-binding and DNA-damaging properties of flavonolignans: a joint experimental and computational highlight based on 7-O-galloylsilybin.

Vacek J, Zatloukalová M, Desmier T, Nezhodová V, Hrbáč J, Kubala M, Křen V, Ulrichová J, Trouillas P.

Chem Biol Interact. 2013 Oct 5;205(3):173-80. doi: 10.1016/j.cbi.2013.07.006. Epub 2013 Jul 18.

PMID:
23872255
16.

Dual phenotypic transmission in Brugada syndrome.

Hermida JS, Arnalsteen-Dassonvalle E, Kubala M, Mathiron A, Traulle S, Anbazhagan K, Hermida A, Rochette J.

Arch Cardiovasc Dis. 2013 Jun-Jul;106(6-7):366-72. doi: 10.1016/j.acvd.2013.04.007. Epub 2013 Jun 28.

17.

Progressive decrease in amplitude of intracardiac ventricular electrogram and higher left ventricular ejection fraction are associated with conductors' externalization in Riata leads.

Kubala M, Traullé S, Leborgne L, Hermida JS.

Europace. 2013 Aug;15(8):1198-204. doi: 10.1093/europace/eut015. Epub 2013 Feb 6.

PMID:
23388185
18.

Prevalence and prognostic significance of 'J waves' in patients experiencing ventricular fibrillation during acute coronary syndrome.

Aïssou L, Hermida JS, Traullé S, Delaverhne A, Diouf M, Leborgne L, Kubala M, Jarry G.

Arch Cardiovasc Dis. 2012 Nov;105(11):578-86. doi: 10.1016/j.acvd.2012.07.005. Epub 2012 Oct 2.

19.

Fluorone dyes have binding sites on both cytoplasmic and extracellular domains of Na,K-ATPase.

Havlíková M, Huličiak M, Bazgier V, Berka K, Kubala M.

Biochim Biophys Acta. 2013 Feb;1828(2):568-76. doi: 10.1016/j.bbamem.2012.10.029. Epub 2012 Nov 8.

20.

The anatomic impact of sequential, additional, ostial radiofrequency ablation following pulmonary vein cryo-isolation.

Traullé S, Miyazaki S, Mouquet V, Kubala M, Hermida JS.

Pacing Clin Electrophysiol. 2012 Dec;35(12):1420-7. doi: 10.1111/j.1540-8159.2012.03521.x. Epub 2012 Sep 28.

PMID:
23020755

Supplemental Content

Loading ...
Support Center